Viewing StudyNCT00085839



Ignite Creation Date: 2024-05-05 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00085839
Status: COMPLETED
Last Update Posted: 2012-08-09
First Post: 2004-06-15

Brief Title: Erlotinib vs Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer NSCLC and Eastern Cooperative Oncology Group ECOGPerformance Status PS 2
Sponsor: OSI Pharmaceuticals
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
Non-Small Cell Lung Cancer
Keywords:
Name View
OSI-774 View
Tarceva View
NSCLC View
EGFR View
ECOG Performance Status 2 View
erlotinib View
Non-Small Cell Lung Cancer View